Clinical Trial Update: A Phase 1 Study of CNTO 3157 in Healthy Volunteers and Patients With Asthma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on CNTO 3157 in healthy volunteers and asthma patients; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CNTO 3157

Snippet

Sponsor: Centocor, Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED